Bezafibrate is a lipid-lowering agent belonging to the fibrate class that is used in the treatment of hyperlipidemia by reducing LDL cholesterol and triglycerides while increasing HDL levels. This category… Read more













Bezafibrate is a lipid-lowering agent belonging to the fibrate class that is used in the treatment of hyperlipidemia by reducing LDL cholesterol and triglycerides while increasing HDL levels. This category provides comprehensive analytical tools for this compound, including the active pharmaceutical ingredient, pharmacopeial and non-pharmacopeial impurities, and stable isotope labelled standards. Pharmaceutical laboratories utilize these reference materials for essential quality control processes, including impurity profiling and rigorous method development in compliance with ICH guidelines. By incorporating structurally related analogs, degradation products such as hydrolysis compounds, and isotope-labelled internal standards, researchers can effectively validate analytical methods, assess drug stability, and ensure the accurate quantification of Bezafibrate in complex matrices. These standards are critical for supporting both stability studies and the ongoing quality assurance of therapeutic formulations throughout their lifecycle.